High level of HIV drug resistance informs dolutegravir roll-out and optimized NRTI backbone strategy in Mozambique

BACKGROUND: HIV drug resistance (HIV-DR) is rising in sub-Saharan Africa in both ART-naive and ART-experienced patients. OBJECTIVES: To estimate the level of acquired DR (ADR) and pre-treatment DR (PDR) across selected urban and rural sites in Southern Africa, in Mozambique. METHODS: We conducted tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Carnimeo, V, Pulido Tarquino, I A, Fuentes, S, Vaz, D, Molfino, L, Tamayo Antabak, N, Cuco, R M, Couto, A, Lobo, S, de Amaral Fidelis, J, Mulassua, J S, Ciglenecki, I, Ellman, T, Schramm, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209982/
https://www.ncbi.nlm.nih.gov/pubmed/34223118
http://dx.doi.org/10.1093/jacamr/dlab050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209982/
https://www.ncbi.nlm.nih.gov/pubmed/34223118
http://dx.doi.org/10.1093/jacamr/dlab050

Ejemplares similares